Ratings by Credit Suisse (Erin Wilson Wirght)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/26/2021 | Elanco Animal Health | ELAN | Upgrade | Outperform (Neutral) |
31.55 (24.91) |
-21.05% | Details | |
| 2/10/2021 | HMS Holdings | HMSY | Maintain | Neutral (N/A) |
|
Details | ||
| 12/22/2020 | HMS Holdings | HMSY | Downgrade | Neutral (Outperform) |
33.78 (36.98) |
9.47% | Details | |
| 8/13/2020 | Elanco Animal Health | ELAN | New Coverage | Neutral (N/A) |
25.42 (24.91) |
-2.01% | Details | |
| 5/11/2020 | HMS Holdings | HMSY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/24/2020 | HMS Holdings | HMSY | Maintain | Outperform (N/A) |
|
Details | ||
| 11/4/2019 | HMS Holdings | HMSY | Maintain | Outperform (N/A) |
|
Details | ||
| 7/10/2019 | HMS Holdings | HMSY | New Coverage | Outperform (N/A) |
33.91 (36.98) |
9.05% | Details | |
| 5/6/2019 | HMS Holdings | HMSY | Maintain | Outperform (N/A) |
|
Details | ||
| 2/27/2019 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 12/24/2018 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 10/15/2018 | Elanco Animal Health | ELAN | New Coverage | Neutral (N/A) |
32.39 (24.91) |
-23.09% | Details | |
| 9/4/2018 | Laboratory Corporation of America | LH | Maintain | Outperform (N/A) |
|
Details | ||
| 8/22/2018 | HMS Holdings | HMSY | Maintain | Outperform (N/A) |
|
Details |
